Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Mar 15;205(6):700-710.
doi: 10.1164/rccm.202107-1612OC.

Race/Ethnicity, Spirometry Reference Equations, and Prediction of Incident Clinical Events: The Multi-Ethnic Study of Atherosclerosis (MESA) Lung Study

Affiliations

Race/Ethnicity, Spirometry Reference Equations, and Prediction of Incident Clinical Events: The Multi-Ethnic Study of Atherosclerosis (MESA) Lung Study

Arielle Elmaleh-Sachs et al. Am J Respir Crit Care Med. .

Abstract

Rationale: Normal values for FEV1 and FVC are currently calculated using cross-sectional reference equations that include terms for race/ethnicity, an approach that may reinforce disparities and is of unclear clinical benefit. Objectives: To determine whether race/ethnicity-based spirometry reference equations improve the prediction of incident chronic lower respiratory disease (CLRD) events and mortality compared with race/ethnicity-neutral equations. Methods: The MESA Lung Study, a population-based, prospective cohort study of White, Black, Hispanic, and Asian adults, performed standardized spirometry from 2004 to 2006. Predicted values for spirometry were calculated using race/ethnicity-based equations following guidelines and, alternatively, race/ethnicity-neutral equations without terms for race/ethnicity. Participants were followed for events through 2019. Measurements and Main Results: The mean age of 3,344 participants was 65 years, and self-reported race/ethnicity was 36% White, 25% Black, 23% Hispanic, and 17% Asian. There were 181 incident CLRD-related events and 547 deaths over a median of 11.6 years. There was no evidence that percentage predicted FEV1 or FVC calculated using race/ethnicity-based equations improved the prediction of CLRD-related events compared with those calculated using race/ethnicity-neutral equations (difference in C statistics for FEV1, -0.005; 95% confidence interval [CI], -0.013 to 0.003; difference in C statistic for FVC, -0.008; 95% CI, -0.016 to -0.0006). Findings were similar for mortality (difference in C statistics for FEV1, -0.002; 95% CI, -0.008 to 0.003; difference in C statistics for FVC, -0.004; 95% CI, -0.009 to 0.001). Conclusions: There was no evidence that race/ethnicity-based spirometry reference equations improved the prediction of clinical events compared with race/ethnicity-neutral equations. The inclusion of race/ethnicity in spirometry reference equations should be reconsidered.

Keywords: chronic lower respiratory disease; pulmonary function tests; race/ethnicity–based reference equations; racism; spirometry.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
(A and B) Distributions of percentage predicted FEV1 (A) and percentage predicted FVC (B) among White, Black, Hispanic, and Asian participants calculated using race/ethnicity–based and race/ethnicity–neutral equations. The solid lines show the distribution of the percentage predicted lung function calculated following guideline-based application of the Global Lung Function Initiative (GLI) race/ethnicity–based reference equations. The dashed lines show the distribution of the percentage predicted lung function calculated using the race/ethnicity–neutral GLI reference equations for “Other.” For the race/ethnicity–based equations, GLI equations are not available for Hispanic individuals, so the GLI equation for White individuals was used (29); GLI equations include two equations for Asian individuals; the one for North East Asians was used.
Figure 2.
Figure 2.
(A–D) Observed 10-year cumulative incidence of chronic lower respiratory disease–related events by percentage predicted FEV1 (A) and percentage predicted FVC (B) and all-cause mortality risk by percentage predicted FEV1 (C) and percentage predicted FVC (D) calculated using race/ethnicity–based and race/ethnicity–neutral equations. The red lines show the 10-year cumulative incidence of chronic lower respiratory disease–related events by percentage predicted FEV1 and FVC (A and B), and the cumulative incidence of all-cause mortality risk by percentage predicted FEV1 and FVC (C and D) calculated using race/ethnicity–based equations following guideline-based application of the Global Lung Function Initiative (GLI) race/ethnicity–based reference equations. The blue lines show the incidence of events calculated using the race/ethnicity–neutral GLI reference equation for “Other.” For the race/ethnicity–based equations, GLI equations are not available for Hispanic individuals, so the GLI equation for White individuals was used (29); GLI equations include two equations for Asian individuals; the one for North East Asians was used. CLRD = chronic lower respiratory disease.

Comment in

References

    1. Hutchinson J. On the capacity of the lungs, and on the respiratory functions, with a view of establishing a precise and easy method of detecting disease by the spirometer. Med Chir Trans . 1846;29:137–252. - PMC - PubMed
    1. Gould BA. New York: Hurd & Houghton; 1869. Investigations in the military and anthropological statistics of American soldiers.
    1. Braun L. Minneapolis: University of Minnesota Press; 2014. Breathing race into the machine: the surprising career of the spirometer from plantation to genetics.
    1. Quanjer PH, Stanojevic S, Cole TJ, Baur X, Hall GL, Culver BH, et al. ERS Global Lung Function Initiative Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations. Eur Respir J . 2012;40:1324–1343. - PMC - PubMed
    1. Graham BL, Steenbruggen I, Miller MR, Barjaktarevic IZ, Cooper BG, Hall GL, et al. Standardization of spirometry 2019 update. An official American Thoracic Society and European Respiratory Society technical statement. Am J Respir Crit Care Med . 2019;200:e70–e88. - PMC - PubMed

Publication types